Clinical Trials
8
Active:1
Completed:4
Trial Phases
1 Phases
Not Applicable:8
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
8 (100.0%)To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake
Not Applicable
Not yet recruiting
- Conditions
- Healthy Women
- First Posted Date
- 2025-09-26
- Last Posted Date
- 2025-09-26
- Lead Sponsor
- Rousselot BVBA
- Target Recruit Count
- 3
- Registration Number
- NCT07195396
- Locations
- 🇩🇪
BioTeSys GmbH, Esslingen am Neckar, Germany
Effect of Chronic Exposure to Nextida GC-B on Glycemic Control in Adults With Normoglycemia and Prediabetes
Not Applicable
Not yet recruiting
- Conditions
- NormoglycemiaPrediabetesGlycemic Control
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Rousselot BVBA
- Target Recruit Count
- 60
- Registration Number
- NCT07149064
- Locations
- 🇨🇦
KGK Science Inc., London, Ontario, Canada
To Assess the Effect of Collagen on Gastrointestinal Discomfort in Healthy Adults With Gastrointestinal Symptoms.
Not Applicable
Active, not recruiting
- Conditions
- Gastrointestinal Disorders
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Rousselot BVBA
- Target Recruit Count
- 116
- Registration Number
- NCT06937801
- Locations
- 🇨🇦
Nutrasource Site (Apex Trials), Guelph, Ontario, Canada
Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile, Gastric Emptying and GLP-1 Release in Normoglycemic and Prediabetic Subjects
Not Applicable
Recruiting
- Conditions
- PrediabetesNormoglycemic
- First Posted Date
- 2025-01-23
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Rousselot BVBA
- Target Recruit Count
- 30
- Registration Number
- NCT06789263
- Locations
- 🇩🇪
BioTeSys GmbH, Esslingen, Germany
An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide
Not Applicable
Completed
- Conditions
- Tolerance
- First Posted Date
- 2024-01-30
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Rousselot BVBA
- Target Recruit Count
- 60
- Registration Number
- NCT06232460
- Locations
- 🇺🇸
Atlantia Clinical Trials, Chicago, Illinois, United States
- Prev
- 1
- 2
- Next
News
No news found